Loading…

Effects of tolerizing sublethal hemorrhage on P44/42 and SAPK/JNK map-kinase activation

Exposure to sublethal hemorrhage (SLH) makes rats tolerant to subsequent hemorrhagic or septic shock. We have shown that this tolerance leads to alterations in cytokine production, macrophage NF-kappaB activation and p38 MAP-kinase activity. The purpose of this study was to explore whether changes i...

Full description

Saved in:
Bibliographic Details
Published in:Shock (Augusta, Ga.) Ga.), 2002-08, Vol.18 (2), p.132-137
Main Authors: CARTER, Yvette, GUOQING LIU, FIER, Adam, MENDEZ, Cynthia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c391t-a2bb3d514bd9d86cfc92de348c5331d524cf7ece34cb542723a0f4d606aeabbc3
cites cdi_FETCH-LOGICAL-c391t-a2bb3d514bd9d86cfc92de348c5331d524cf7ece34cb542723a0f4d606aeabbc3
container_end_page 137
container_issue 2
container_start_page 132
container_title Shock (Augusta, Ga.)
container_volume 18
creator CARTER, Yvette
GUOQING LIU
FIER, Adam
MENDEZ, Cynthia
description Exposure to sublethal hemorrhage (SLH) makes rats tolerant to subsequent hemorrhagic or septic shock. We have shown that this tolerance leads to alterations in cytokine production, macrophage NF-kappaB activation and p38 MAP-kinase activity. The purpose of this study was to explore whether changes in p44/42 and SAPK/JNK MAP kinase activity also occur after the induction of tolerance by SLH. Rats were made tolerant by SLH (mean arterial pressure = 30 mmHg for 15 min with shed blood returned). Shams had anesthesia and instrumentation only. Twenty-four hours after SLH or sham operation, LPS was given (40 mg/kg intraperitoneal). Lung, liver, and splenic tissues were harvested 15, 30, and 45 min following sham, SLH, or LPS. Protein was isolated from tissues for determination of p44/42 and SAPK/JNK phosphorylation by Western blot analysis. Phosphorylation of p44/42 and SAPK/JNK was detected in all tissues following both sham and SLH, and this effect was significantly more pronounced following SLH (P < 0.05). However, activation of both p44/42 and SAPK/JNK in response to LPS, was significantly lower in the SLH rats when compared to shams. Peak activation was seen 30 min after SLH and peak attenuation, 30 min after LPS. The amount of nonphosphorylated protein was comparable in all groups. The induction of tolerance by SLH leads to phosphorylation of both p44/42 and SAPK/JNK MAP-kinases. However, the activation of these same kinases is attenuated in response to LPS in animals made tolerant by SLH.
doi_str_mv 10.1097/00024382-200208000-00007
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71973694</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71973694</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-a2bb3d514bd9d86cfc92de348c5331d524cf7ece34cb542723a0f4d606aeabbc3</originalsourceid><addsrcrecordid>eNpFkMtOwzAQRS0EoqXwC8gb2IX6lThZVlV5tYJKgFhGE8duA3kUO0GCr8e0gS4sz4zOtUcHIUzJFSWJHBNCmOAxC5gvSOzbwB8iD9CQhsI3IRWHviaSB4wzNkAnzr1tQ4k8RgPKaBRJGQ7R68wYrVqHG4PbptS2-C7qFXZdVup2DSVe66qxdg0rjZsaL4UYC4ahzvHTZDkf3z_McQWb4L2owWkMqi0-oS2a-hQdGSidPuvvEXq5nj1Pb4PF483ddLIIFE9oGwDLMp77bbM8yeNIGZWwXHMRq5BzmodMKCO18hOVhYJJxoEYkUckAg1ZpvgIXe7e3djmo9OuTavCKV2WUOumc6mkieRRIjwY70BlG-esNunGFhXYr5SS9Fdq-ic1_ZeabqX66Hn_R5dVOt8He4seuOgBcApKY6FWhdtzPKYi5JT_AA_Xfkc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71973694</pqid></control><display><type>article</type><title>Effects of tolerizing sublethal hemorrhage on P44/42 and SAPK/JNK map-kinase activation</title><source>Freely Accessible Science Journals - check A-Z of ejournals</source><creator>CARTER, Yvette ; GUOQING LIU ; FIER, Adam ; MENDEZ, Cynthia</creator><creatorcontrib>CARTER, Yvette ; GUOQING LIU ; FIER, Adam ; MENDEZ, Cynthia</creatorcontrib><description>Exposure to sublethal hemorrhage (SLH) makes rats tolerant to subsequent hemorrhagic or septic shock. We have shown that this tolerance leads to alterations in cytokine production, macrophage NF-kappaB activation and p38 MAP-kinase activity. The purpose of this study was to explore whether changes in p44/42 and SAPK/JNK MAP kinase activity also occur after the induction of tolerance by SLH. Rats were made tolerant by SLH (mean arterial pressure = 30 mmHg for 15 min with shed blood returned). Shams had anesthesia and instrumentation only. Twenty-four hours after SLH or sham operation, LPS was given (40 mg/kg intraperitoneal). Lung, liver, and splenic tissues were harvested 15, 30, and 45 min following sham, SLH, or LPS. Protein was isolated from tissues for determination of p44/42 and SAPK/JNK phosphorylation by Western blot analysis. Phosphorylation of p44/42 and SAPK/JNK was detected in all tissues following both sham and SLH, and this effect was significantly more pronounced following SLH (P &lt; 0.05). However, activation of both p44/42 and SAPK/JNK in response to LPS, was significantly lower in the SLH rats when compared to shams. Peak activation was seen 30 min after SLH and peak attenuation, 30 min after LPS. The amount of nonphosphorylated protein was comparable in all groups. The induction of tolerance by SLH leads to phosphorylation of both p44/42 and SAPK/JNK MAP-kinases. However, the activation of these same kinases is attenuated in response to LPS in animals made tolerant by SLH.</description><identifier>ISSN: 1073-2322</identifier><identifier>EISSN: 1540-0514</identifier><identifier>DOI: 10.1097/00024382-200208000-00007</identifier><identifier>PMID: 12166775</identifier><language>eng</language><publisher>Augusta, GA: BioMedical Press</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Biomarkers - analysis ; Blotting, Western ; Disease Models, Animal ; Emergency and intensive care: infection, septic shock ; Intensive care medicine ; JNK Mitogen-Activated Protein Kinases ; Male ; MAP Kinase Kinase 4 ; Medical sciences ; Mitogen-Activated Protein Kinase 1 - analysis ; Mitogen-Activated Protein Kinase 1 - metabolism ; Mitogen-Activated Protein Kinase Kinases - analysis ; Mitogen-Activated Protein Kinase Kinases - metabolism ; Mitogen-Activated Protein Kinases - analysis ; Mitogen-Activated Protein Kinases - metabolism ; p38 Mitogen-Activated Protein Kinases ; Probability ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Sensitivity and Specificity ; Severity of Illness Index ; Shock, Hemorrhagic - enzymology ; Shock, Hemorrhagic - physiopathology</subject><ispartof>Shock (Augusta, Ga.), 2002-08, Vol.18 (2), p.132-137</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-a2bb3d514bd9d86cfc92de348c5331d524cf7ece34cb542723a0f4d606aeabbc3</citedby><cites>FETCH-LOGICAL-c391t-a2bb3d514bd9d86cfc92de348c5331d524cf7ece34cb542723a0f4d606aeabbc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13814531$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12166775$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CARTER, Yvette</creatorcontrib><creatorcontrib>GUOQING LIU</creatorcontrib><creatorcontrib>FIER, Adam</creatorcontrib><creatorcontrib>MENDEZ, Cynthia</creatorcontrib><title>Effects of tolerizing sublethal hemorrhage on P44/42 and SAPK/JNK map-kinase activation</title><title>Shock (Augusta, Ga.)</title><addtitle>Shock</addtitle><description>Exposure to sublethal hemorrhage (SLH) makes rats tolerant to subsequent hemorrhagic or septic shock. We have shown that this tolerance leads to alterations in cytokine production, macrophage NF-kappaB activation and p38 MAP-kinase activity. The purpose of this study was to explore whether changes in p44/42 and SAPK/JNK MAP kinase activity also occur after the induction of tolerance by SLH. Rats were made tolerant by SLH (mean arterial pressure = 30 mmHg for 15 min with shed blood returned). Shams had anesthesia and instrumentation only. Twenty-four hours after SLH or sham operation, LPS was given (40 mg/kg intraperitoneal). Lung, liver, and splenic tissues were harvested 15, 30, and 45 min following sham, SLH, or LPS. Protein was isolated from tissues for determination of p44/42 and SAPK/JNK phosphorylation by Western blot analysis. Phosphorylation of p44/42 and SAPK/JNK was detected in all tissues following both sham and SLH, and this effect was significantly more pronounced following SLH (P &lt; 0.05). However, activation of both p44/42 and SAPK/JNK in response to LPS, was significantly lower in the SLH rats when compared to shams. Peak activation was seen 30 min after SLH and peak attenuation, 30 min after LPS. The amount of nonphosphorylated protein was comparable in all groups. The induction of tolerance by SLH leads to phosphorylation of both p44/42 and SAPK/JNK MAP-kinases. However, the activation of these same kinases is attenuated in response to LPS in animals made tolerant by SLH.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - analysis</subject><subject>Blotting, Western</subject><subject>Disease Models, Animal</subject><subject>Emergency and intensive care: infection, septic shock</subject><subject>Intensive care medicine</subject><subject>JNK Mitogen-Activated Protein Kinases</subject><subject>Male</subject><subject>MAP Kinase Kinase 4</subject><subject>Medical sciences</subject><subject>Mitogen-Activated Protein Kinase 1 - analysis</subject><subject>Mitogen-Activated Protein Kinase 1 - metabolism</subject><subject>Mitogen-Activated Protein Kinase Kinases - analysis</subject><subject>Mitogen-Activated Protein Kinase Kinases - metabolism</subject><subject>Mitogen-Activated Protein Kinases - analysis</subject><subject>Mitogen-Activated Protein Kinases - metabolism</subject><subject>p38 Mitogen-Activated Protein Kinases</subject><subject>Probability</subject><subject>Random Allocation</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sensitivity and Specificity</subject><subject>Severity of Illness Index</subject><subject>Shock, Hemorrhagic - enzymology</subject><subject>Shock, Hemorrhagic - physiopathology</subject><issn>1073-2322</issn><issn>1540-0514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpFkMtOwzAQRS0EoqXwC8gb2IX6lThZVlV5tYJKgFhGE8duA3kUO0GCr8e0gS4sz4zOtUcHIUzJFSWJHBNCmOAxC5gvSOzbwB8iD9CQhsI3IRWHviaSB4wzNkAnzr1tQ4k8RgPKaBRJGQ7R68wYrVqHG4PbptS2-C7qFXZdVup2DSVe66qxdg0rjZsaL4UYC4ahzvHTZDkf3z_McQWb4L2owWkMqi0-oS2a-hQdGSidPuvvEXq5nj1Pb4PF483ddLIIFE9oGwDLMp77bbM8yeNIGZWwXHMRq5BzmodMKCO18hOVhYJJxoEYkUckAg1ZpvgIXe7e3djmo9OuTavCKV2WUOumc6mkieRRIjwY70BlG-esNunGFhXYr5SS9Fdq-ic1_ZeabqX66Hn_R5dVOt8He4seuOgBcApKY6FWhdtzPKYi5JT_AA_Xfkc</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>CARTER, Yvette</creator><creator>GUOQING LIU</creator><creator>FIER, Adam</creator><creator>MENDEZ, Cynthia</creator><general>BioMedical Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020801</creationdate><title>Effects of tolerizing sublethal hemorrhage on P44/42 and SAPK/JNK map-kinase activation</title><author>CARTER, Yvette ; GUOQING LIU ; FIER, Adam ; MENDEZ, Cynthia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-a2bb3d514bd9d86cfc92de348c5331d524cf7ece34cb542723a0f4d606aeabbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - analysis</topic><topic>Blotting, Western</topic><topic>Disease Models, Animal</topic><topic>Emergency and intensive care: infection, septic shock</topic><topic>Intensive care medicine</topic><topic>JNK Mitogen-Activated Protein Kinases</topic><topic>Male</topic><topic>MAP Kinase Kinase 4</topic><topic>Medical sciences</topic><topic>Mitogen-Activated Protein Kinase 1 - analysis</topic><topic>Mitogen-Activated Protein Kinase 1 - metabolism</topic><topic>Mitogen-Activated Protein Kinase Kinases - analysis</topic><topic>Mitogen-Activated Protein Kinase Kinases - metabolism</topic><topic>Mitogen-Activated Protein Kinases - analysis</topic><topic>Mitogen-Activated Protein Kinases - metabolism</topic><topic>p38 Mitogen-Activated Protein Kinases</topic><topic>Probability</topic><topic>Random Allocation</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sensitivity and Specificity</topic><topic>Severity of Illness Index</topic><topic>Shock, Hemorrhagic - enzymology</topic><topic>Shock, Hemorrhagic - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CARTER, Yvette</creatorcontrib><creatorcontrib>GUOQING LIU</creatorcontrib><creatorcontrib>FIER, Adam</creatorcontrib><creatorcontrib>MENDEZ, Cynthia</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Shock (Augusta, Ga.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CARTER, Yvette</au><au>GUOQING LIU</au><au>FIER, Adam</au><au>MENDEZ, Cynthia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of tolerizing sublethal hemorrhage on P44/42 and SAPK/JNK map-kinase activation</atitle><jtitle>Shock (Augusta, Ga.)</jtitle><addtitle>Shock</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>18</volume><issue>2</issue><spage>132</spage><epage>137</epage><pages>132-137</pages><issn>1073-2322</issn><eissn>1540-0514</eissn><abstract>Exposure to sublethal hemorrhage (SLH) makes rats tolerant to subsequent hemorrhagic or septic shock. We have shown that this tolerance leads to alterations in cytokine production, macrophage NF-kappaB activation and p38 MAP-kinase activity. The purpose of this study was to explore whether changes in p44/42 and SAPK/JNK MAP kinase activity also occur after the induction of tolerance by SLH. Rats were made tolerant by SLH (mean arterial pressure = 30 mmHg for 15 min with shed blood returned). Shams had anesthesia and instrumentation only. Twenty-four hours after SLH or sham operation, LPS was given (40 mg/kg intraperitoneal). Lung, liver, and splenic tissues were harvested 15, 30, and 45 min following sham, SLH, or LPS. Protein was isolated from tissues for determination of p44/42 and SAPK/JNK phosphorylation by Western blot analysis. Phosphorylation of p44/42 and SAPK/JNK was detected in all tissues following both sham and SLH, and this effect was significantly more pronounced following SLH (P &lt; 0.05). However, activation of both p44/42 and SAPK/JNK in response to LPS, was significantly lower in the SLH rats when compared to shams. Peak activation was seen 30 min after SLH and peak attenuation, 30 min after LPS. The amount of nonphosphorylated protein was comparable in all groups. The induction of tolerance by SLH leads to phosphorylation of both p44/42 and SAPK/JNK MAP-kinases. However, the activation of these same kinases is attenuated in response to LPS in animals made tolerant by SLH.</abstract><cop>Augusta, GA</cop><pub>BioMedical Press</pub><pmid>12166775</pmid><doi>10.1097/00024382-200208000-00007</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1073-2322
ispartof Shock (Augusta, Ga.), 2002-08, Vol.18 (2), p.132-137
issn 1073-2322
1540-0514
language eng
recordid cdi_proquest_miscellaneous_71973694
source Freely Accessible Science Journals - check A-Z of ejournals
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Biological and medical sciences
Biomarkers - analysis
Blotting, Western
Disease Models, Animal
Emergency and intensive care: infection, septic shock
Intensive care medicine
JNK Mitogen-Activated Protein Kinases
Male
MAP Kinase Kinase 4
Medical sciences
Mitogen-Activated Protein Kinase 1 - analysis
Mitogen-Activated Protein Kinase 1 - metabolism
Mitogen-Activated Protein Kinase Kinases - analysis
Mitogen-Activated Protein Kinase Kinases - metabolism
Mitogen-Activated Protein Kinases - analysis
Mitogen-Activated Protein Kinases - metabolism
p38 Mitogen-Activated Protein Kinases
Probability
Random Allocation
Rats
Rats, Sprague-Dawley
Sensitivity and Specificity
Severity of Illness Index
Shock, Hemorrhagic - enzymology
Shock, Hemorrhagic - physiopathology
title Effects of tolerizing sublethal hemorrhage on P44/42 and SAPK/JNK map-kinase activation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T01%3A01%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20tolerizing%20sublethal%20hemorrhage%20on%20P44/42%20and%20SAPK/JNK%20map-kinase%20activation&rft.jtitle=Shock%20(Augusta,%20Ga.)&rft.au=CARTER,%20Yvette&rft.date=2002-08-01&rft.volume=18&rft.issue=2&rft.spage=132&rft.epage=137&rft.pages=132-137&rft.issn=1073-2322&rft.eissn=1540-0514&rft_id=info:doi/10.1097/00024382-200208000-00007&rft_dat=%3Cproquest_cross%3E71973694%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c391t-a2bb3d514bd9d86cfc92de348c5331d524cf7ece34cb542723a0f4d606aeabbc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71973694&rft_id=info:pmid/12166775&rfr_iscdi=true